Regeneron board adopts annual say-on-pay vote frequency after shareholder approval

REGENERON PHARMACEUTICALS, INC.

Shareholders voted for every-one-year frequency at June 9, 2023 annual meeting.
Board on Sept 8, 2023 determined future advisory votes on exec compensation will be held annually.
Amendment filed solely to disclose the board's decision; no other changes to original report.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

REGENERON PHARMACEUTICALS, INC. shareholders approved Advisory vote on the frequency of future shareholder votes on executive compensation at the 2023-06-09 meeting.

Proposal: say on pay frequency
Outcome: passed
Meeting: 2023-06-09

Exact text from the filing

As reported by the Company in the Original Report, a frequency of every one year received a majority of the votes cast on the proposal.

View on SEC.gov

Browse all shareholder votes →

REGENERON PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-099351

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.